SOURCE: Nanomix, Inc.

September 19, 2007 07:00 ET

Nanomix to Webcast Corporate Presentation at the UBS Global Life Sciences Conference

EMERYVILLE, CA--(Marketwire - September 19, 2007) - Nanomix, Inc., a leading nanoelectronic detection company commercializing high-value medical diagnostic and monitoring applications, today announced that President and CEO, David Macdonald, will present a corporate overview on Monday, September 24, 2007 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) during the UBS Global Life Sciences Conference. The conference is taking place at the Grand Hyatt New York in New York City. During his presentation, Mr. Macdonald will provide an overview of the Company's pipeline and Sensation™ detection platform. A breakout session for discussion will follow.

About Nanomix:

Nanomix is a leading nanoelectronic detection company launching detection devices based on Sensation™ technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across high value respiratory and biomarker detection applications where low power consumption, small size, and ultra-sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit www.nano.com.

Contact Information

  • Contact:
    Bill Perry
    Vice President of Sales, Marketing and Business Development
    Phone: 510-428-5300
    Email: Email Contact